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A B S T R A C T
Vagus nerve stimulation (VNS) is a promising therapy for treatment of various conditions that are resistant to
standard medication, such as heart failure, epilepsy, and depression. The vagus nerve is a complex nerve pro-
viding afferent and efferent innervation of the pharynx, larynx, heart, tracheobronchial tree and lungs, oeso-
phagus, stomach, liver, pancreas, small intestine and proximal colon. It is therefore a prime target for inter-
vention for VNS. Surprisingly, the fascicular organisation of the vagus nerve at the cervical level is still not well
understood. This, along with the current stimulation techniques, results in the entire nerve being stimulated,
which leads to unwanted off-target effects. Neuronal tracing is a promising method to delineate the organ-
specific innervation by the vagus nerve, thereby providing valuable insight into the fascicular anatomy. In this
review we discuss the current knowledge of vagus nerve anatomy and neuronal tracers used for mapping of its
organ-specific projections in various species. Efferent vagal projections are a chain of two neurones (pre- and
postganglionic), while afferent projections consist of only one pseudounipolar neurone with one branch ter-
minating in the target organ/tissue directly and another in the brainstem. It would be feasible to retrogradely
trace the afferent fibres from their respective visceral targets and identify them at the cervical level using non-
transsynaptic neuronal tracers. Using this to create a map of the functional anatomical organisation of the vagus
nerve will enable selective VNS ultimately allowing for the avoidance of the off-target effects and improving
overall efficacy.
1. Introduction – Neuronal tracing for delineation of vagal
fascicular anatomy
Pharmacological therapy and surgical intervention are the most
commonly used approaches for treatment of various pathologies
(Mishra, 2017). However, definite side effects continue to prevail for all
known drugs, surgeries and non-surgical interventions (de Boer et al.,
2013; Dunlop, 1969; Zimmerman, 1999). The brain, nervous system
and endocrine system (via neural impulse communications through
complex neural circuitry) regulate functions of all internal organs. Most
drugs act on or interfere with neurotransmitters and their receptors, or
endocrine system mechanisms (Locatelli et al., 2009). In order to avoid
these side effects, the new field of bioelectronics medicine, Electro-
ceuticals, was born. Electroceuticals employs electrical stimulation of
nerves to treat diseases instead of administering drugs or performing
complex surgical procedures (Famm et al., 2013; Kollewe, 2017;
Mishra, 2017). Electrical impulses (or action potentials) are the lan-
guage of the nervous system which result in regulation of virtually all
organs and functions (Famm et al., 2013; “The Brain and Nervous
System,” 2006). Electroceuticals can modulate these neural impulses to
recover lost function and revive a healthy balance (Famm et al., 2013;
Mishra, 2017).
A prime target for intervention is the cervical vagus nerve (Blount,
2015; Ekmekçi and Kaptan, 2017; Guiraud et al., 2016; Koopman et al.,
2016; Pečlin and Rozman, 2014; Smucny et al., 2015). The vagus nerve,
also known as cranial nerve X, innervates numerous visceral organs and
muscles; including the pharynx, larynx, heart, lungs, muscles of the
bronchi and gut. The human cervical left and right vagi consist of ap-
proximately 10–15 individual fascicles (Verlinden et al., 2016), but,
surprisingly, the organisation of fascicles, functional, anatomical or
other, within the vagus nerve remains almost completely unknown. The
vagus nerve follows a complex anatomical path and crosses several
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plexuses and ganglia along its thoracoabdominal course. Electrical sti-
mulation of the cervical vagus nerve has been successfully used to re-
duce depression, arthritis and the frequency of epileptic seizures
(Binnie, 2000; De Ferrari and Schwartz, 2011; Ripplinger, 2017). At the
moment, however, stimulation techniques and lack of understanding of
fascicular anatomy allow for only the entire nerve to be activated or
suppressed. Therefore, with the considerable innervation by the vagus
nerve, whole nerve stimulation inevitably leads to off-target side effects
with organs other than those intended being stimulated (Ripplinger,
2017). Knowledge of the functional anatomy of fibres could be helpful
not only in avoiding side effects but also in improving the efficacy of
vagus nerve stimulation (VNS) overall by better understanding of the
mapping of vagal fibres to both peripheral organs and originating brain
regions.
In our research group, we are developing methods to enable selec-
tive stimulation of fascicles within the cervical vagus nerve (Aristovich
et al., 2019). We are currently investigating the functional anatomy of
the vagus nerve using neural tracers, electrophysiology with multi-
electrode arrays, computerised tracing with microCT and the new
method of fast neural Electrical Impedance Tomography (EIT). This
review has arisen from this work as we strive to understand the fasci-
cular functional anatomy of the vagus nerve in order to allow selective
VNS and avoid off-target effects.
With a known fascicular organisation of the vagus nerve, selective
stimulation could be used to target specific organs or effectors for
neuromodulation and avoid adverse off-target effects. Preliminary
studies have shown this is possible using cuff electrodes optimised for
selective stimulation in sheep, dogs and humans (Aristovich et al.,
2019; Pečlin et al., 2009; Rozman and Bunc, 2004). Stimulation
through a pair of electrodes in the same radial position on two rings of
14 electrodes in a cylindrical multielectrode nerve cuff array in the
sheep allows for selective neuromodulation of cardiac, pulmonary and
recurrent laryngeal activity in the vagus nerve; evidence is yet to be
obtained to show that function is localised to individual fascicles, but
these results already suggest that such function is localised within the
nerve (Aristovich et al., 2019). Corresponding localised activity could
be imaged using the same nerve cuff and fast neural EIT (Aristovich
et al., 2019). It is thus hypothesized that there is functional organotopic
organisation of the fascicles in the cervical vagus nerve (Aristovich
et al., 2019; Prechtl and Powley, 1987); the evidence for which is the
three notable regions identified in the above mentioned research: car-
diac, pulmonary and recurrent laryngeal. To account for inter-in-
dividual differences, tracing techniques in animal studies may enable
estimation of the degree of variation; however, the non-invasive EIT
technique could be used to provide subject-specific fascicular mapping
and so inform targeted stimulation.
Neuroanatomical tracing with neuronal markers is a widely used
technique for tracing projections in the central nervous system (CNS)
and, to a lesser extent, has also been applied in the peripheral nervous
system (PNS). In theory, it could be helpful in delineating the functional
anatomy in the human autonomic nervous system (ANS). However, it
requires continuity of the neuronal processes and may become in-
effective for tracing axons over the long distances needed for autonomic
nerves in large mammals such as the human. The question remains
Fig. 1. General schema of the autonomic nervous system.
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whether this would be feasible for tracing fascicles in the cervical vagus
nerve, considering the complexity of the vagus nerve anatomical path.
In this review, we discuss the current knowledge of functional anato-
mical organisation of the vagus nerve and plausible techniques for
neuroanatomical tracing of its individual organ-specific fascicles to
ascertain the fascicular organisation.
2. Purpose
Neuroanatomical mapping of organ-specific projections of the vagus
nerve would require imaging and tracing of the afferent and efferent
fascicles. First, we review and discuss studies of vagal innervation in
humans and experimental animals. Next, we discuss the strategies to
choose the appropriate neuronal tracer(s) based on their mechanisms of
action, axonal transport and the targeted projections (afferent or ef-
ferent). We conclude with recommendations on the most appropriate
tracing approaches.
3. Vagus nerve
The ANS, a division of the PNS, comprises sympathetic and para-
sympathetic divisions (Fig. 1) (Felten et al., 2016; Waxman, 2017).
Often described as the visceral system, the ANS comprises visceral af-
ferent (sensory) and visceral efferent fibres; the latter are either para-
sympathetic or sympathetic (Amann and Constantinescu, 1990). The
visceral efferent division is a two-neurone chain with preganglionic
neurones which arise from the brainstem or spinal cord and synapse on
postganglionic neurones in various types of ganglia which connect them
to visceral target organs (Felten et al., 2016; Marieb, 2010). The sym-
pathetic nervous system is a thoracolumbar system derived from neu-
rones in the T1-L2 lateral horn. It prepares the body for fight-or-flight
reactions by acting through sympathetic chain and collateral ganglia
(e.g. coeliac ganglia) (Marieb, 2010; McCorry, 2007). The para-
sympathetic division, also known as the craniosacral system, consists of
cranial nerves (CNs III, VII, IX and X) and spinal nerves in the sacrum
(S2-S4) (Felten et al., 2016). All CNs arise from brainstem and CNS
nuclei, and CNs III, VII and IX synapse at cranial nerve ganglia (ciliary,
pterygopalatine, otic or submandibular) before completing their
journey to target tissues via trigeminal branches (Türkmen et al., 2015;
Watson, 2012). Unlike the other cranial nerves, the vagus nerve (CN X),
along with the sacral nerves that arise from intermediate grey matter in
the spinal cord, acts through intramural ganglia which lie within or
near the target tissue (Rea, 2014; Sibilla and Agarwal, 2018). The
parasympathetic nervous system is a regulatory and homeostatic re-
parative system responsible for rest-and-digest activity stimulation
when the body is at rest (McCorry, 2007). Both autonomic divisions
work together with most connections acting through vagal and sym-
pathetic preganglionic neurones (Felten et al., 2016).
The vagus nerve is the main nerve of the parasympathetic division
of the ANS (Pavlov and Tracey, 2012). However, it is a mixed nerve
containing branchial motor, visceral sensory, visceral motor, and spe-
cial and general sensory components (Rea, 2014). The vagus nerve
contains 80 to 90% afferent fibres (sensory) and 10 to 20% efferent
(motor) fibres (Beckett et al., 2017). It is the longest cranial nerve with
extensive distribution below the level of the head (Felten et al., 2016;
Rea, 2014; Sibilla and Agarwal, 2018). Despite the gross anatomy of the
vagus nerve being well studied, its fascicular functional anatomy re-
mains almost completely unknown. The vagus nerve includes axons
which emerge from or converge onto four nuclei of the brainstem: the
dorsal nucleus of the vagus nerve (DVMN) – which sends para-
sympathetic motor output to intramural ganglia associated with thor-
acic and abdominal viscera and supplies autonomic innervation to the
heart, the lungs, and the gastrointestinal tract (GIT) to the descending
colon, the nucleus ambiguus – which gives rise to the branchial ef-
ferent motor fibres of the vagus nerve and preganglionic para-
sympathetic neurones that innervate the heart, the solitary nucleus
(NTS) – which receives afferent taste information and primary afferents
from visceral organs, and the spinal trigeminal nucleus – which re-
ceives information about deep/crude touch, pain, and temperature of
the outer ear, the dura of the posterior cranial fossa and the mucosa of
the larynx (Câmara and Griessenauer, 2015; Felten et al., 2016; Rea,
2014).
In addition, vagal brainstem nuclei establish multiple central af-
ferent and efferent connections in brain regions involved in affective
autonomic and other interoceptive reflexive functions. Major central
afferent connections from the NTS are derived from hypothalamus and
central nucleus of amygdala. In turn, the NTS sends the axonal pro-
jections terminating in numerous autonomic brain regions, such as
brainstem reticular formation, parabrachial nucleus, periaqueductal
grey, amygdala, and hypothalamus. Therefore, the NTS provides the
autonomic affective functional basis for homeostatic control of the
whole body (Nieuwenhuys et al., 2008). The nucleus ambiguus and
DVMN also receive multiple projections from various brain regions,
including Raphe nuclei and hypothalamus (Manaker and Fogarty, 1995;
Roges et al., 1980), thus providing an anatomic substrate for central
modulation of parasympathetic function.
From the origin in the brainstem in the CNS (Hermanowicz, 2007),
the filaments of the vagus nerve travel towards the jugular foramen
where the vagus nerve runs through caudal to the glossopharyngeal
nerve and superficial to the internal jugular vein (Ellis, 2006; Waldman,
2011). Within and inferior to the jugular foramen lie the two ganglia
associated with the vagus nerve, the superior (jugular) and inferior
(nodose) ganglia, respectively (Câmara and Griessenauer, 2015; Ellis,
2006; Rea, 2014). Both motor and sensory fibres pass through the ju-
gular ganglion, whilst only some sensory fibres (namely, visceral af-
ferent) have cell bodies in the nodose ganglion. The jugular ganglion
contains the cell bodies of the general somatic afferent fibres, specifi-
cally from the external ear (Rea, 2014). The nodose ganglion is pri-
marily concerned with visceral afferent fibres and their cell bodies for
the relaying of information from the pharynx and thoracic and ab-
dominal viscera (Câmara and Griessenauer, 2015; Rea, 2014). The left
and right vagus nerves subsequently descend in their own anterolateral
compartments, the carotid sheaths, and run between the internal ju-
gular vein and the internal and external carotid arteries, and continue
into the thorax and abdomen where they innervate the heart, tra-
cheobronchial tree and lungs, oesophagus, stomach, pancreas, liver and
GIT via numerous branches.
There are also sympathetic ganglia which are anatomically close to
vagal nerve branches. These are the collateral ganglia of the sympa-
thetic nervous system which include the coeliac ganglion and the su-
perior and inferior mesenteric ganglia. The collateral ganglia lie close to
the vagal nerve path and are often confused to be vagus nerve ganglia.
Parasympathetic preganglionic neurones may appear to pass through
the collateral ganglia, especially when traveling through a plexus;
however, no synapses take place. Therefore, they are anatomically and
functionally separate. Sympathetic preganglionic axons, as part of the
spinal nerves, leave the CNS, pass through the sympathetic chain
ganglia and synapse in these collateral or prevertebral ganglia; whilst
some synapse already with postganglionic neurones within the sym-
pathetic chain ganglia and others pass through all ganglia and continue
to the adrenal glands (Furness, 2015; Gibbins, 2012; Szurszewski and
Linden, 2012; Waldman, 2009).
The cell bodies of the efferent parasympathetic preganglionic neu-
rones are located in the abovementioned DVMN and nucleus ambiguus
of the brainstem (Watson, 2012; Weaver, 1980). The cell bodies of
parasympathetic postganglionic neurones are located within the in-
tramural ganglia (Furness, 2009; Johnson, 2013) – ganglia so named for
their positioning within or near the organs they innervate (Langley,
1921). Efferent fibres pass through the jugular and nodose ganglia
without synapsing. Therefore, there are synapses between the pre- and
postganglionic visceral efferent fibres occurring only within the in-
tramural ganglia near to the target organ (McCorry, 2007; Molnar and
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Gair, 2013).
Visceral afferent fibres are pseudounipolar with the neurone con-
taining an axon that splits into two branches; from the cell bodies,
which are collectively located in the jugular and nodose ganglia as
mentioned above, the peripheral branches extend uninterrupted to the
periphery and the central ones to the CNS where they centrally synapse
in the solitary and spinal trigeminal nuclei (Varga and Mravec, 2015).
Therefore, there are no synapses of the visceral afferent fibres other
than in the target organ or in the nuclei of the brainstem of the CNS.
Various types of neurones form signalling circuits such as a reflex
arc. Multiple afferent and efferent neurones are connected by inter-
neurones which are exclusively located within the CNS. This allows for
one motor neurone to be affected by multiple sensory neurones and one
sensory neurone to affect multiple motor neurones (Lodish et al., 2000).
When a reflex involves only one central synapse within the CNS be-
tween afferent and efferent neurones, this is known as monosynaptic.
The vagus nerve makes use of polysynaptic reflexes which involve one
or more interneurones (Craighead and Nemeroff, 2000).
In summary, the vagus nerve sends efferent parasympathetic ac-
tivity via the preganglionic neurones originating in the DVMN and the
nucleus ambiguus that project to the terminal intramural ganglia of the
thoracic and abdominal cavities which lie within or near to the target
organs. Here, they synapse with postganglionic neurones that project
from the intramural ganglia a short distance to the target effector, or to
the specific target tissue within the organ. The vagus nerve then con-
veys information from visceral tissues and organs via afferent
sensory fibres projecting directly from the target organs to the solitary
and spinal trigeminal nuclei of the brainstem, with the cell bodies of
these neurones located in the inferior and superior cervical ganglia of
the vagus nerve. Interneurones located within the CNS relay the in-
formation from the afferent fibres to the efferent fibres allowing in-
tegration of sensory information at the level of brainstem and control of
parasympathetic efferent output to periphery to maintain body home-
ostasis.
3.1. Innervation and functions of the vagus nerve
The vagus nerve has efferent and afferent functions. With regards to
the former, the vagus nerve innervates, through a motor component,
the majority of the muscles associated with the pharynx and larynx via
the pharyngeal branch and the superior and recurrent laryngeal nerves,
respectively (Felten et al., 2016; Rea, 2014). Additionally, a large part
of the efferent function is the parasympathetic supply to the visceral
organs. Those well-known to receive parasympathetic innervation from
the vagus nerve include: the heart, tracheobronchial tree and lungs,
oesophagus, stomach, liver, pancreas, small intestine and proximal
colon (Agostoni et al., 1957; Câmara and Griessenauer, 2015;
Hermanowicz, 2007; Pavlov and Tracey, 2012; Rea, 2014; Sibilla and
Agarwal, 2018; Waldman, 2011). Thoracic and abdominal commu-
nicating branches between the left and right vagal trunks have been
described in some species, with afferent and/or efferent axons from one
side crossing over to the other side. In the rat, there is little evidence for
crossing of efferent axons, while about 20% of afferents cross from one
side to another at the thoracic level (Berthoud and Neuhuber, 2000).
The vagal innervation of kidneys, spleen, adrenal glands and re-
productive organs is highly debated. For a long time, it has been gen-
erally accepted that the parasympathetic innervation to the kidneys was
from the vagus nerve. However, some studies proved that there is no
convincing neuroanatomical evidence for parasympathetic innervation
of the kidney (Jobling, 2011; Kopp, 2011). Retrograde tracing with
True Blue and Fast Blue injected into the kidneys in rats resulted in
labelled cells in the dorsal root ganglia (T8-L2), nodose ganglia of the
vagus nerve, as well as throughout the DVMN and NTS (Donovan et al.,
1983). However, the presence of the similar number of labelled neu-
rones in these same locations after injections into the tail vein of rats
with denervated kidneys indicates that labelling may be non-specific
(Donovan et al., 1983). All other attempts to trace parasympathetic
projections to the kidney using retrograde tracers showed that there is
no vagal innervation of this organ (Jobling, 2011).
The parasympathetic innervation of the spleen is an ongoing debate.
Neuroanatomical and neurochemical evidence in rats demonstrates that
neural innervation of the spleen is entirely sympathetic in origin,
mainly via the sympathetic splanchnic nerves, and indicates that there
is no evidence for parasympathetic or sensory input to the spleen
(Nance and Sanders, 2007). Retrograde (Horse radish peroxidase (HRP)
and FluoroGold) (Nance and Burns, 1989), as well as transneuronal
tracers (pseudorabies virus) (Cano et al., 2001) were used without
providing evidence of vagal innervation. Absence of choline acetyl-
transferase (ChAT) in the spleen, which is a specific marker of choli-
nergic nerve fibres, further proves absence of parasympathetic in-
nervation (Bellinger et al., 1993). In contrast, studies indicate that the
spleen is required for the cytokine regulatory effect of VNS despite all
the evidence that the vagus nerve does not directly innervate this organ
(Bellinger et al., 1993; Berthoud and Powley, 1993; Koopman et al.,
2016; Rosas-Ballina et al., 2008). This may differ between species
(Kooijman et al., 2015), however, it has since been revealed that there
is indeed no vagal innervation to the spleen and the anti-inflammatory
effect of VNS is due to the vagal efferent fibres activating the sympa-
thetic and adrenergic neurones supplying the spleen. This is mediated
via activation of alpha-7 nicotinic acetylcholine receptors on sympa-
thetic fibres running in the splenic nerve and affecting cytokine pro-
duction in the spleen (Browning et al., 2017; Gautron et al., 2013).
Similarly to the spleen, the adrenal glands are innervated sym-
pathetically. Sympathetic preganglionic nerve fibres from neurones in
the T10–L1 intermediolateral cell column pass through the sympathetic
chain, travel in splanchnic nerves, and directly innervate adrenal me-
dullary chromaffin cells (Câmara and Griessenauer, 2015; Ellis, 2006;
Felten et al., 2016). However, some studies indicate that the vagus
nerve does supply innervation to the adrenal glands, at least in some
species (Berthoud and Powley, 1993; Coupland et al., 1989; Niijima,
1992; Parker et al., 1993). This confusion may be attributed to the role
the vagus nerve plays in anti-inflammatory responses as with the
spleen, mentioned above (Nance and Sanders, 2007).
There is a debate whether the reproductive organs receive para-
sympathetic innervation derived from the sacral S2-S4 nerves from the
intermediate grey matter of the spinal cord (which also innervate the
bladder and lower urinary tract (Chancellor and Yoshimura, 2002)) or
from the vagus nerve. The course of the vagus nerve beyond the sto-
mach is very diffuse, thus making it difficult to follow the vagal in-
nervation beyond this point (Câmara and Griessenauer, 2015; Ellis,
2006). There are some studies, however, showing that the vagus nerve
may serve as a connection between the reproductive organs and CNS
(Collins et al., 1999; Gerendai, 2004; Linares et al., 2013; Pastelín et al.,
2017). The argument has been made that the parasympathetic origin to
the reproductive organs is from the vagus nerve as opposed to the
splanchnic nerves due to the embryonic origin of the ovaries (Brauer
and Smith, 2015; Gerendai et al., 2002).
Regarding the afferent function of the vagus nerve, there are so-
matic and visceral components, as well as a special sensory component
(Rea, 2014). Somatic refers to sensation from the skin and muscles. This
component is provided by the auricular branch of the vagus nerve
which innervates the skin of the back of the ear and external auditory
meatus, parts of the external surface of the tympanic membrane, and
the pharynx (Rea, 2014). Special sensory component refers to a minor
role of the vagus nerve in taste sensation via afferent fibres from the
root of the tongue and epiglottis (Câmara and Griessenauer, 2015; Rea,
2014). The visceral sensory component is responsible for the trans-
mission of information from the visceral organs and represents the most
interest for the therapeutic applications of vagal stimulation (Blount,
2015; De Ferrari and Schwartz, 2011; Rea, 2014).
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3.2. Fibre composition and molecular characterisation of vagus nerve
The cell bodies of the majority of vagal afferent neurones reside in
the nodose ganglion. Nearly all vagal sensory neurones innervating
subdiaphragmatic structures are unmyelinated C-fibres (Prechtl and
Powley, 1990). Vagal afferent fibres innervating thoracic structures,
such as the respiratory tract and oesophagus, however, are more diverse
and comprise about 50% unmyelinated C-fibres and 50% myelinated A-
fibres. Vagal sensory A-fibres comprise primarily low-threshold stretch-
sensitive receptors. These are referred to as slowly adapting and rapidly
adapting receptors in the lungs (Sant’Ambrogio and Widdicombe,
2001) and as tension (mechano)receptors (structurally intraganglionic
laminar nerve endings, IGLEs) in the oesophagus (Zagorodnyuk et al.,
2003). In addition, a touch- and acid-sensitive Aδ cough receptor has
been described in the trachea (Mazzone et al., 2009). A subset of vagus
sensory afferents, including unmyelinated C-fibres and myelinated Aδ-
fibres, express TRPV1 (transient receptor potential cation channel
subfamily V member 1) – a ligand-gated non-selective calcium perme-
able ion channel, also known as the capsaicin receptor and the vanilloid
receptor 1 (Caterina et al., 1997; Nakagawa and Hiura, 2006). It in-
tegrates multiple physical and chemical stimuli, including vanilloid
compounds, low pH, and noxious heat. With respect to C-fibres, two
distinct phenotypes of capsaicin-sensitive nociceptive C-fibres, referred
to as neural crest C-fibres and placodal C-fibres, have been identified in
both the respiratory tract and oesophagus (Kollarik et al., 2010; Undem
et al., 2004). ATP-sensitive channel P2× 3 is predominantly expressed
by myelinated A-fibres but is also found on a subset of unmyelinated
vagal afferent fibres (Hermes et al., 2016). The high conductance cal-
cium-activated potassium channel K(Ca)1.1 was shown to be ex-
clusively expressed by unmyelinated visceral afferent fibres (Li et al.,
2011).
In conclusion, there is convincing evidence that the cervical vagus
nerve innervates the following organs: the heart, tracheobronchial tree
and lungs, oesophagus, stomach, liver, pancreas, small intestine and
proximal colon. This includes both parasympathetic efferent innerva-
tion, via pre- and postganglionic nerve fibres that synapse within in-
tramural ganglia, and afferent sensory innervation with continuous fi-
bres from brainstem to target organ. This suggests that, at least in
principle, it should be possible to label the fascicular path to or from
these organs using the available neuronal tracers.
4. Neuronal tracing
Neuronal tracers label axon paths to allow delineation of the con-
nectivity in the nervous system (Carter and Shieh, 2015). These are
chemical probes that can be classified by the direction they travel
within the neurone. Anterograde tracing refers to transport from the
cell body to the synapse; retrograde tracing refers to labelling from the
synaptic terminal back to the cell body (the opposite direction) (Carter
and Shieh, 2015). Some tracers are capable of working in both direc-
tions whereas some are restricted to only anterograde or retrograde
transport. A revolution in neurobiology in the 1970s was experienced
when HRP was introduced as a retrograde tracer for mapping of long-
distance neuronal projections (Kristensson and Olsson, 1971; Lavail and
Lavail, 1972). When injected into target organ/tissue, HRP is taken up
by peripheral autonomic nerves by means of passive endocytosis
(Broadwell et al., 1984, 1980). Retrograde transport occurs in small
vesicles that tend to fuse and accumulate HRP at high densities in the
nerve facilitating the visibility of the final reaction product (van der
Want et al., 1997). Visualisation of the transported HRP is achieved
during immunocytochemistry; HRP oxidises a substrate in the presence
of hydrogen peroxide into an insoluble polymer which is then detect-
able by light and electron microscopy (Ribatti, 2017). Until then, tra-
cing neuronal pathways often required laborious dissections by hand,
or involved Wallerian degeneration – histological description of de-
generating axons following lesions of the nerve or brain regions (Waller
and Owen, 1850). This lesion-based method was greatly improved by
the discovery that degenerating myelinated fibres can be visualised
with silver staining technique (Marchi, 1886; Strich, 1968) which gave
a driving force to several decades of classical neuroanatomy.
Since the introduction of HRP as a neuroanatomical tracer, many
other substances have been identified and used, such as bacterial toxins,
plant lectins, viruses and fluorescent molecules (Heimer and Záborszky,
1989; Rajakumar et al., 1993). These tracers may be fluorescent or
produce a colorimetric product subsequent to reaction with a substrate.
Examples of classical tracers include HRP, biotinylated dextran amines,
FluoroGold, Fast Blue and Diamidino Yellow. Modern molecular tech-
niques have enabled the construction of recombinant forms of viruses,
such as the adeno-associated virus (AAV), that can be designed to de-
liver genetically encoded fluorescent protein (for example, green
fluorescent protein, GFP) to the neurones for anterograde tracing of
long axonal pathways (Chamberlin et al., 1998). The GFP fills the soma
and then diffuses down the length of the axon to show targets of the
nerve fibres (Carter and Shieh, 2015).
The use of anterograde or retrograde tracing requires the applica-
tion of a tracer into the tissue of interest in a live animal during a re-
covery experiment via one of three methods: pressure injection, ion-
tophoretic injection, or mechanical insertion of dye crystals (Köbbert
et al., 2000). After an optimal incubation period, the tissue of interest is
excised, processed and examined for the presence of the tracer. Neu-
ronal tracing is often combined with other techniques such as im-
munohistochemistry or electrophysiology (Carter and Shieh, 2015;
Köbbert et al., 2000). Classical tracing techniques result in the illumi-
nation of direct connections within the nervous system (i.e. from cell
body to synapse, or vice versa). However, occasionally, scientists want
to study the neural circuitry across multiple synapses. For this, the use
of transsynaptic tracers is required. These include radioactively labelled
amino acids such as 3H-leucine, plant lectins such as wheat germ ag-
glutinin, and viruses such as pseudorabies and herpes simplex viruses
(Beier et al., 2011; Carter and Shieh, 2015; Kuypers and Ugolini, 1990;
Song et al., 2005; Tuncdemir and Fishell, 2011; Ugolini, 2010). Ad-
ditionally, proteins such as tetanus toxin can be used for transsynaptic
labelling (Cabot et al., 1991; Evinger and Erichsen, 1986; Horn and
Büttner-Ennever, 1990; Schwab et al., 1979). However, available
methods for transsynaptic labelling have proven to either not be highly
efficient (Gerfen and Sawchenko, 1984; Kissa et al., 2002; Schwab
et al., 1979) or to have high toxicity (Ekstrand et al., 2008; Lo and
Anderson, 2011; Wickersham et al., 2007).
Three uptake mechanisms of tracers exist: active uptake, passive
incorporation and intracellular injection (Köbbert et al., 2000). Tracers
can enter axons by active uptake via either nerve terminals, allowing
for intramuscular injections, or injured neuritic profiles (Köbbert et al.,
2000). Both pathways can be successful (Liang et al., 2015); however,
some tracers are more readily taken up by one or the other. For ex-
ample, dextran amines are more efficiently taken up by injured nerves
(Choi et al., 2002; Fritzsch and Sonntag, 1991), while Fast Blue is more
readily taken up by intact nerve terminals (Hayashi et al., 2007).
Substances can also passively diffuse into neurones due to the local
concentration gradient (Köbbert et al., 2000). Lastly, if single cells are
accessible, tracers can be directly delivered to the cytosol of the neu-
rone. Similar to uptake, transport and distribution of the tracers within
the cells take place via active transport in the vesicles or lateral diffu-
sion within the plane of the membrane (Köbbert et al., 2000). Active
transport, which appears to be the only efficient mode for longer dis-
tances in vivo, occurs by means of pH-trapping or ingestion of labelled
membrane fragments, followed by tracer accumulation in vesicles and
active transport along the cytoskeleton of axons (Abbott et al., 2013;
Köbbert et al., 2000). The lateral diffusion results in much smoother
labelling of the complete extension of the neural processes and, as it is
based on passive diffusion, this can be exploited for the use in a fixed
tissue (Godement et al., 1987).
The choice of non-viral neuronal tracers depends on several factors
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including their labelling efficiency and uptake mechanisms. Several
molecules such as carbo-cyanine dyes, beads, dextrans, lectins, amino
acids, inorganic fluorescent molecules and bacterial toxins have been
previously used as non-viral neuronal tracers. Among these several
options, inorganic fluorescent molecules have the key features of an
ideal neuronal tracer, which include selectivity, efficiency and avail-
ability for multi-colour labelling. Important factors to be considered
when choosing a neuronal tracer are: a) duration of time to label the
target after the dye application; b) duration of fluorescent labelling
after uptake (how long the fluorescent labelling lasts); and c) labelling
efficiency of the candidate neuronal tracer which is determined by
proportion of cells labelled and intensity of labelling. The time required
for the dye to label nerves and neurones innervating a certain tissue/
organ varies significantly and depends on the type of the chosen neu-
ronal tracer and structure of the targeted organ undergoing the dye
injections. In addition, other factors should be considered. Animal
species and the length of neuronal projection from the target organ
(e.g., heart vs colon) to the neuronal tracer’s final destination (e.g.,
nodose ganglia) are the additional critical factors influencing the time
of the labelling period. The time sufficient for a neuronal tracer to
travel along the nerves and provide consistent labelling outcome needs
to be optimised for each particular tracer/target organ/species. For
example, Fast Blue is reported to produce labelling as early as two days
after injections into mouse airways (Kaelberer and Jordt, 2016) but
takes 1–2 weeks to label vagal afferent/efferent projections to abdom-
inal organs in pigs (Zalecki, 2015). An ideal tracer for neuroanatomical
mapping would allow labelling the neurones without affecting their
function, have a long half-life and specificity. Viral vectors are broadly
used for mapping and selective manipulation of neuroanatomical pro-
jections within the central nervous system.
In the peripheral nervous system, studies of viral gene transfer have
mainly focused on the dorsal root ganglion neurones and studies re-
lating to pain (Glatzel et al., 2000; Mason et al., 2010; Storek et al.,
2008; Xu et al., 2003). There are very few studies that report the use of
recombinant viral technology in tracing of vagal afferent pathways.
Wild-type neurotropic viruses, such as rabies virus from Rabdoviridae
and pseudorabies virus, and alpha-herpes virus, are the two main
classes of viral transneuronal tracers. Despite good tracing qualities,
these viral vectors have high toxicity which typically leads to low levels
of expression and variable results. In the last 20 years, there has been a
methodological revolution in neuronal tracing with the development of
genetically modified viruses and use of other viral species, including
AAVs. There is a large number of naturally occurring serotypes of AAVs
which differ by capsid proteins and sequences in their inverted terminal
repeats – sequences required for replication of viral genome. The dif-
ferent serotypes demonstrate distinct cellular tropism, transduction
efficiency, speed of onset of viral gene expression and distribution
patterns in infected cells (Aschauer et al., 2013; Haenraets et al., 2017).
Use of AAVs for tracing in peripheral nervous system represents a
higher level of complexity compared to tracing in CNS. Firstly, it is the
dilution factor – when injected into CNS structures, the number of viral
particles getting in direct contact with targeted neurones is significantly
higher than when the vector is injected into peripheral organ/tissue
(Aschauer et al., 2013). Secondly, the majority of AAV serotypes utilise
anterograde axonal transport (from neuronal cell body to axonal pro-
jections) more efficiently than retrograde (from neural terminals to cell
body – the direction which needs to be targeted when tracing organ-
specific projections of the vagus nerve) (Aschauer et al., 2013). Re-
cently, new AAV capsids were developed for efficient and non-invasive
gene transfer to central and peripheral nervous system; namely, AAV-
PHP.eB and AAV-PHP.S (Challis et al., 2019). However, such studies
have only been performed in transgenic mice until now. For example, in
their work on identification of peripheral neural circuits regulating
heart rate, Rajendran et al. (Rajendran et al., 2019) administered Cre-
dependent AAV-PHP.S vectors expressing a fluorescent reporter gene
into ChAT-IRES Cre mice. Such two-component expression system
allows cell type-specific labelling of parasympathetic cholinergic neu-
rones. When injected systemically, the AAV-PHP.S serotype does not
allow organ-specific tracing, while injection into organ or tissue does
not produce satisfactory results because this serotype is not transported
retrogradely. The only AAV variant that permits efficient retrograde
access to projection neurones with efficiency comparable to classical
retrograde tracers is a newly evolved rAAV-retro (Tervo et al., 2016).
This rAAV-retro gene delivery system is now being used on its own or in
conjunction with Cre recombinase driver lines to achieve transgene
expression for tracing and selective manipulation of neuronal popula-
tions projecting to peripheral organs/tissues. A combinatorial viral
approach to target and manipulate vagal sensory neurones of the upper
gut with the use of rAAV-retro was employed by Han et al. (Han et al.,
2018) – the Cre-inducible viral optogenetic construct was injected into
the nodose ganglia of mice that received organ-specific peripheral in-
jections of rAAV-retro to express Cre-recombinase. Cre-recombinase
was readily detected in enteric neurones of the upper GIT and double-
infected neurones were optogenetically manipulated to interrogate
sensory pathways involved in gut-mediated reward (Han et al., 2018).
This work demonstrates the feasibility of the approach with the use of
rAAV-retro in tracing of organ-specific vagal afferent projections.
Whether this AAV serotype can be used as successfully for retrograde
tracing in large animals as in small rodents, needs to be investigated.
4.1. Approaches to non-selectively label all vagal afferents or efferents
To label all abdominal fibres in a rat non-selectively, FluoroGold
can be injected via intraperitoneally. After five days, all abdominal
vagal afferents are labelled (Zheng et al., 2005). True Blue can be in-
fused intraperitoneally (3mg per rat) to non-specifically label all vagal
afferent and preganglionic efferent neurones innervating viscera
(Sterner et al., 1985). Alternatively, red fluorescent dye Dextran–Texas
Red can be injected into the nodose ganglion. After 14 days, all sensory
(afferent) fibres are labelled with red fluorescent marker (Walter et al.,
2009). To label vagal abdominal efferent fibres non-selectively, red
fluorescent dye Dextran–Texas Red can be pressure injected into
DVMN. Nineteen days later, all subdiaphragmatic efferent fibres are
labelled (Walter et al., 2009).
4.2. Neuronal tracing of organ-specific projections of vagus nerve
4.2.1. Heart
In large animals, to maximise the efficiency of labelling, the injec-
tion points for the neuronal tracers for the heart should be in close
proximity or directly into cardiac plexus which is found at the base of
the heart. The cardiac plexus is generally divided into superficial and
deep portions. The superficial portion lies beneath the aortic arch, just
in front of the right pulmonary artery, and is formed by the superior
branches of the left sympathetic nerves and the lower superior cervical
branches of the left vagus nerve. The deep cardiac plexus lies in front of
the tracheal bifurcation behind the aortic arch and is formed by cardiac
nerves arising from the cervical ganglia of the sympathetic trunk and
cardiac branches of the vagus and recurrent laryngeal nerves. From an
electrophysiological perspective, the right-sided nerves tend to supply
the sinoatrial (SA) node while the left-sided nerves tend to supply the
atrioventricular node (Kapa et al., 2016). In rats, direct injections of
HRP (3–5 μl bolus of 30% HRP in saline) into the upper right atrium
near SA node or in the mid-ventricular region were performed to trace
vagal projections to the heart (Stuesse, 1982). After 24–48 hours of
recovery, the labelled cell bodies of vagal preganglionic neurones were
predominantly found in the nucleus ambiguus forming a column of cells
within the nucleus extending 240 μm in the rostral-caudal direction.
The success of this approach suggests it is possible to achieve retrograde
labelling of vagal efferents innervating SA node via injections of the
tracer into cardiac muscle in close proximity to the SA node. Whether it
is feasible in large animals, still needs to be tested.
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4.2.2. Trachea
Vagal cough receptor sensory neurones in the trachea can be vi-
sualised by FluoroGold labelling: in guinea pigs, 10 μl of 4% FluoroGold
was injected into the rostral extrathoracic trachea lumen on to the
mucosal surface. Seven days post-injection, about 3% of neurones
within the nodose ganglion were labelled with FluoroGold (Mazzone
and McGovern, 2008).
4.2.3. Oesophagus
Vagal afferent neurones were successfully traced using AAV2/8
viral vectors in the guinea pig (Kollarik et al., 2010). The eGFP encoded
by adeno-associated virus vectors was transported to both the central
and peripheral terminals when the virus was injected into the nodose
ganglion. AAV2/8 vectors were also efficiently taken up by vagal nerve
terminals in the visceral tissue (when injected into oesophageal wall)
and retrogradely transported to the cell bodies (residing in nodose
ganglion). A total of 20 μl of AAV2/8 vector (1012 viral particles/ml)
were injected directly into the cervical oesophageal wall. Seven weeks
after injection, GFP was expressed in right and left nodose ganglia
(Kollarik et al., 2010). In rats, Fast Blue was used for retrograde la-
belling of vagal afferents in subdiaphragmatic oesophagus. Four injec-
tions each containing 2 μl of 4% Fast Blue solution were applied into the
oesophageal muscle below the diaphragm (Banerjee et al., 2009). Two
weeks after injection, the Fast Blue-labelled cell bodies were found in
nodose ganglion (Banerjee et al., 2009).
4.2.4. Pancreas
Vagal afferent projections to the pancreas mostly innervate the head
of the pancreas and to the lesser extent the tail (Fasanella et al., 2008),
and the number of neurones projecting from the left nodose ganglion is
almost twice as high as from the right (Fasanella et al., 2008). Pan-
creatic sensory afferents can be labelled by direct injection of the tracer
into the parenchyma of the organ. In mice, 5 μl of 2% Cholera toxin
subunit B (CTB) conjugated to Alexa Fluor 488/555/647 were injected
across three sites into the duodenal lobe pancreatic parenchyma using
glass micropipette, and four days after the injection the tracer was vi-
sualised in the nodose ganglion (Fasanella et al., 2008). Alternatively,
tracing can be performed with True Blue: 5–10 μl of True Blue in dis-
tilled water (5%) was injected into the duodenal and splenic lobes of
the pancreas at 8–12 loci, and seven days after injection the labelled
cell bodies of pancreatic sensory afferents were visualised in nodose
ganglion (Su et al., 1987).
4.2.5. Liver
About 30% of the fibres in the common hepatic branch are of non-
vagal (adventitial) origin (Prechtl and Powley, 1990). Sensory vagal
fibres in the liver are restricted to the stroma surrounding triads of
hepatic vasculature and bile ducts, and to extrahepatic portions of the
portal vein and bile ducts. For vagal afferent innervation, retrograde
and anterograde tracing studies in the rat have clearly shown that only
a minor portion of the common hepatic branch innervates the liver
area, while the major portion descends in the gastroduodenal branch
toward the duodenum, pancreas, and pylorus. Hepatic paraganglia, bile
ducts, and the portal vein receive the densest vagal afferent innervation
(Berthoud, 2004). Studies with retrograde tracer HRP injections (40 μl
of 21% HRP) into various compartments of liver revealed that the
smallest number of labelled vagal afferent neurones is found following
direct injections into hepatic parenchyma. Injection into the hilus area
was more effective, while injections into common bile duct was 10-fold
more efficient (Magni and Carobi, 1983). These findings led to the
conclusion that the majority of axons travelling in the hepatic branch
terminate in bile ducts. More than half of the fibres travelling in hepatic
branch innervate the pylorus and first part of duodenum (Berthoud,
2004).
4.2.6. Gastrointestinal tract: small and large intestine
Majority of the sensory neurones that innervate intestinal villi
(mechano- and chemoreceptors) contain the receptor GPR65 (Williams
et al., 2016). Selective activation of these neurones causes a powerful
blockade of gastric contractions without impacting breathing or heart
rate, which are also under vagal control. In a fixed tissue from murine
embryos and neonates, DiI was used to label and trace the vagus nerve
supplying the GIT; DiI crystals were inserted directly into the anterior
trunk of subdiaphragmatic vagus nerve (Murphy and Fox, 2007). After
allowing three weeks for diffusion of the Dil, the GIT was imaged for the
presence of the tracer that anterogradely labelled vagal afferents.
4.2.7. Stomach and duodenum
In rats, vagal innervation of stomach and duodenum can be traced
with True Blue or CTB-conjugates. 5–10 μl of True Blue in distilled
water (5%) was injected into anterior and posterior walls of the sto-
mach at 8–12 loci with a Hamilton microsyringe. Histology performed
seven days after the dye injection revealed labelled neuronal cell bodies
in the nodose ganglia (Su et al., 1987). Fluorescent conjugate of CTB
with Alexa Fluor 555 was injected into the wall of the stomach and
duodenum using glass capillary loaded with 10 μl of tracer (0.5% so-
lution of CTB-555 in saline). One week later, the labelled cell bodies of
afferent neurones can be quantified in the nodose ganglia (Diepenbroek
et al., 2017).
4.2.8. Mucosal tracing in the stomach
The vagal sensory afferents innervating stomach mucosa in rats can
be labelled with CTB-Alexa Fluor conjugates. Animals have to be fasted
to minimize the amount of food in the stomach, and mucolytic agent
has to be applied prior to the neuronal tracer to maximise the tracer
uptake. 0.5% CTB-555 was injected into the lumen of the stomach
(60 μl) using a glass capillary. After one week, the labelled cell bodies of
sensory neurones were visualised in the nodose ganglia (Diepenbroek
et al., 2017).
4.2.9. Colon
As for the stomach and duodenum, vagal innervation of the colon in
rats can be traced with CTB-555. A 0.5% solution of CTB-555 was in-
jected into ventral and dorsal sides of the first 2 cm of ascending colon
(distributed over 10 injection sites, 5 μl of the tracer in total) and the
labelled cell bodies of afferent neurones were visualised in the nodose
ganglion (Diepenbroek et al., 2017).
Regarding neuronal tracing in large animals, the majority of studies
of vagal sensory innervation in pigs is performed with the use of ret-
rograde fluorescent tracer Fast Blue: 20 μl of 5% aqueous suspension of
Fast Blue was injected with a Hamilton microsyringe across 4–5 sites
into the organ/tissue of interest in young pigs (body weight approx.
20 kg), and histology was performed 10–15 days after injection
(Zalecki, 2015). The techniques suitable for neuronal tracing in small
laboratory animals often fail in the larger species. For example, no
sensory parasympathetic neurones in nodose ganglion were labelled
when using CTB-HRP in pigs (Zalecki, 2015).
5. Conclusion
The vagus nerve innervates numerous organs including the heart,
tracheobronchial tree and lungs, oesophagus, pancreas, liver, stomach,
small intestine and proximal colon, as well as the muscles associated
with the pharynx and larynx. The vagal innervation to the spleen,
kidneys, adrenal glands and reproductive organs is highly debated.
Sensory fibres of the vagus nerve run uninterrupted, with no synapsing,
directly from the target effectors to the solitary and spinal trigeminal
nuclei of the brainstem where the afferent information is processed and
relayed to the DVMN and the nucleus ambiguus. Preganglionic neu-
rones residing in these nuclei project to the terminal intramural ganglia
within or near the target organs where they synapse on the
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postganglionic neurones that project from the intramural ganglia to the
target effector, or to the specific target tissue within the organ.
Neuronal tracing has been successfully implemented to trace vagal
innervation of all the thoracic and abdominal organs. The majority of
the studies were performed in small laboratory animals for tracing of
the afferent neuronal projections from the innervated organ to the cell
bodies residing in nodose ganglia. For neuronal tracers utilizing active
mechanisms of axonal transport, this results in labelling of the cell
bodies exclusively. For efficient axonal labelling along the entire nerve,
the passively diffusing tracers or viral vectors need to be used. Even
with the use of non-transsynaptic neuronal tracers, tracing of the fas-
cicular anatomy of the afferent fibres to determine the arrangement and
localisation of fascicles within the cervical vagus nerve appears to be
feasible. These fibres can be retrogradely traced when the tracer is in-
jected into parenchyma of the innervated organ or into the smooth
muscle wall or submucosal layer of the organ of GIT (stomach, duo-
denum, ileum, and jejunum). When tracing efferent fibres, the tracer
has to be injected into the brainstem nuclei where the cell bodies of
vagal preganglionic neurones reside (DVMN or nucleus ambiguus)
taking into account the viscerotopic organisation of the brainstem nu-
clei. However, the organ specificity of such central approach to label
vagal efferent fibres is unlikely to reach 100% due to significant overlap
of viscerotopic columns of vagal preganglionic neurones within brain-
stem nuclei (Berthoud et al., 1991). Tracing of efferent fibres using
monosynaptic tracers will result in the labelling termination in the in-
tramural ganglia. Otherwise, transsynaptic tracers, although not op-
timal, should be used.
A good starting point for using neuronal tracers to map the fasci-
cular anatomy of nerves would be to begin with those used successfully
in the literature (Table 1). However, it would be advantageous if the
same neuronal tracer would work for each organ of interest, which
requires method development and optimisation.
Neuroanatomical tracing will allow mapping of the fascicular
anatomy of the vagus nerve from the numerous target effectors to the
cervical level. However, additional information on the functional
anatomy and potential reflex activity of the vagus nerve will also need
to be taken into account. Such a map of the functional anatomical or-
ganisation of the vagus nerve will enable selective stimulation of fas-
cicles innervating the organ/tissue of interest, which will ultimately
help to avoid the off-target effects so frequently experienced during
VNS and improve its therapeutic efficacy.
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